Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey Beckman who wrote (725)	2/26/1998 6:33:00 PM
From: AllenP	Read Replies (1) \| Respond to of 1055

Message from THRX message board on Yahoo.com Investors business daily highlights THRX today on pg A29. Nice writeup and probably responsible for todays surge. For those in the dark about the business and the future of prostate brachy, its pretty informative (though it unfairly slams external beam results).

To: Jeffrey Beckman who wrote (725)	3/6/1998 2:17:00 AM
From: Michael Paul Langley	Read Replies (1) \| Respond to of 1055

I am concerned that THRX price may gap down (5 pts or so)from the price at the time when they report 1st Q earnings as $.19 is the expected number which would be down from $.22 from 4th Q 97 (a decrease, or even flat growth in earnings will surely send the momentum players fleeing). With the same 4 cyclos running at probably full capacity this shouldn't come as any shock to anyone. I'm not sure the date that they expect to report but I would expect that we may revisit the mid-high $40's. Average of the 5 analysts covering THRX (4 strong buy and 1 moderate buy )have fiscal 97 earnings at $.83 (26% increase from 97) and $1.39 a share in fiscal 99. The goal of 4 new cyclotrons (8 total)up and running by the end of 1998 is very aggressive indeed (no question THRX can sell sell of everything they can currently produce). However THRX's original goal of 6 cyclotrons up and running by the end of 97 (according to SSR, June 1996) wasn't met so I would expect we would probably be lucky to have 6 cyclos running by end of 98 fiscal year. Presently not concerned with NASI (I am looking closely at this complimentary company as a investment)or Inis as competition as I believe the demand is currently there for additional niche players in the brachytherapy market. Further discussion is hereby encouraged on #'s, cyclos, competition, etc.